Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Harmony Biosciences
AddedFeb 19, 2024
UpdatedJul 4, 2026
Harmony Biosciences

Harmony Biosciences

Public

Harmony Biosciences: Innovating therapies for rare neurological disorders in the U.S.

HQ
Plymouth Meeting, PA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Harmony Biosciences, founded in the U.S., is a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients with rare neurological disorders. The company's core mission is to address unmet medical needs through cutting-edge science, translating it into therapeutic possibilities. Harmony Biosciences offers a range of treatments aimed at improving the quality of life for individuals suffering from these conditions, with a strong emphasis on patient-centric care.

Notable figures affiliated with Harmony Biosciences include experienced professionals from the pharmaceutical industry and key investors who support its mission. The company has achieved significant milestones, including the successful development and commercialization of new treatments that have made a meaningful impact on patients' lives. Harmony Biosciences continues to drive innovation in the field of neurology, contributing to advancements in medical science and offering hope to those affected by rare neurological diseases.

Harmony Biosciences - Similar Companies

Bioharmony Therapeutics logo

Bioharmony Therapeutics

Neurovia logo

Neurovia

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

Amylyx Pharmaceuticals logo

Amylyx Pharmaceuticals

amylyx.com

SpringWorks Therapeutics logo

SpringWorks Therapeutics

springworkstx.com

Ovid Therapeutics logo

Ovid Therapeutics

ovidrx.com

Neurogene logo

Neurogene

neurogene.com

Catalyst Pharmaceuticals logo

Catalyst Pharmaceuticals

catalystpharma.com

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

Halia Therapeutics logo

Halia Therapeutics

Cogent Biosciences logo

Cogent Biosciences

cogentbio.com

Acorda Therapeutics logo

Acorda Therapeutics

acorda.com

Praxis Precision Medicines logo

Praxis Precision Medicines

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Assertio Holdings logo

Assertio Holdings

Harmony Biosciences - Quick Facts

Who are Harmony Biosciences' competitors?

Companies similar to Harmony Biosciences include Bioharmony Therapeutics, Neurovia, Astria Therapeutics and Amylyx Pharmaceuticals.

When was Harmony Biosciences founded?

Harmony Biosciences was founded in 2017.

Where is Harmony Biosciences' headquarters located?

Harmony Biosciences' headquarters is located in Plymouth Meeting, PA, US.

When was Harmony Biosciences' last funding round?

Harmony Biosciences' most recent funding round was for $185M (USD) in July 2023.

How much has Harmony Biosciences raised to-date?

As of Jul 27, 2023, Harmony Biosciences has raised a total of $1.2B (USD).

How many employees does Harmony Biosciences have?

Harmony Biosciences has 200 employees as of Feb 6, 2024.

Harmony Biosciences - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
  • Healthtech
Unique IDs
  • secCik: 0001802665
  • ticker: HRMY
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research